Antibiotics (Nov 2022)

A Novel Machine Learning-Based Point-Score Model as a Non-Invasive Decision-Making Tool for Identifying Infected Ascites in Patients with Hydropic Decompensated Liver Cirrhosis: A Retrospective Multicentre Study

  • Silvia Würstle,
  • Alexander Hapfelmeier,
  • Siranush Karapetyan,
  • Fabian Studen,
  • Andriana Isaakidou,
  • Tillman Schneider,
  • Roland M. Schmid,
  • Stefan von Delius,
  • Felix Gundling,
  • Julian Triebelhorn,
  • Rainer Burgkart,
  • Andreas Obermeier,
  • Ulrich Mayr,
  • Stephan Heller,
  • Sebastian Rasch,
  • Tobias Lahmer,
  • Fabian Geisler,
  • Benjamin Chan,
  • Paul E. Turner,
  • Kathrin Rothe,
  • Christoph D. Spinner,
  • Jochen Schneider

DOI
https://doi.org/10.3390/antibiotics11111610
Journal volume & issue
Vol. 11, no. 11
p. 1610

Abstract

Read online

This study is aimed at assessing the distinctive features of patients with infected ascites and liver cirrhosis and developing a scoring system to allow for the accurate identification of patients not requiring abdominocentesis to rule out infected ascites. A total of 700 episodes of patients with decompensated liver cirrhosis undergoing abdominocentesis between 2006 and 2020 were included. Overall, 34 clinical, drug, and laboratory features were evaluated using machine learning to identify key differentiation criteria and integrate them into a point-score model. In total, 11 discriminatory features were selected using a Lasso regression model to establish a point-score model. Considering pre-test probabilities for infected ascites of 10%, 15%, and 25%, the negative and positive predictive values of the point-score model for infected ascites were 98.1%, 97.0%, 94.6% and 14.9%, 21.8%, and 34.5%, respectively. Besides the main model, a simplified model was generated, containing only features that are fast to collect, which revealed similar predictive values. Our point-score model appears to be a promising non-invasive approach to rule out infected ascites in clinical routine with high negative predictive values in patients with hydropic decompensated liver cirrhosis, but further external validation in a prospective study is needed.

Keywords